Progesterone: nanograms per milliliter (ng/mL), nanomoles per liter (nmol/L).
Estradiol: picograms per milliliter (pg/mL), picomoles per liter (pmol/L).
What Is the Progesterone to Estrogen Ratio?
The Progesterone to Estrogen Ratio (Pg/E2) compares the concentration of progesterone (Pg) to estradiol (E2), the most biologically active form of estrogen.
Why estradiol (E2)?
- The body produces several estrogens (estradiol, estrone, estriol), but estradiol is the dominant and most potent estrogen in cycling women.
- It is therefore the primary estrogen used in clinical assessment of hormonal balance.
Purpose of the Pg/E2 ratio
The Pg/E2 ratio helps explain how progesterone and estradiol work together across the cycle. Instead of looking at each hormone in isolation, this ratio looks at their relationship.
That relationship matters because estrogen and progesterone have opposite but complementary roles. Estradiol helps build and thicken the uterine lining. Progesterone helps stabilize and mature that lining after ovulation. In simple terms, estrogen prepares the tissue, while progesterone helps organize and calm the response.
When progesterone is too low compared with estradiol, estrogen may have a stronger effect, even if estradiol itself appears “normal.” This pattern is often discussed as estrogen dominance, meaning estrogen activity is not being properly balanced by progesterone.
This is where hormone tracking becomes useful. Ovul focuses on estrogen induced patterns through saliva based ferning analysis and AI image interpretation. While Ovul does not measure progesterone directly, it can help users follow estrogen trends over time. That added visibility may make it easier to understand where estrogen fits into the broader hormone balance conversation, especially when paired with cycle symptoms, ovulation timing, and clinical testing when needed.
When should the Pg/E2 ratio be measured?
For cycling women, the ratio is meaningful only if measured at the mid-luteal phase, typically:
- 5–7 days after ovulation,
- around day 19–22 of a 28-day cycle.
Timing matters. After ovulation, the corpus luteum should be producing progesterone, while estradiol remains present at a supportive level. This is the window where progesterone and estrogen balance can be evaluated more meaningfully.
Testing too early can be misleading. In the follicular phase, estrogen is naturally more active and progesterone is naturally low. That can create a low Pg/E2 ratio that is completely normal for that part of the cycle.
This is where Ovul can support better timing. By helping users track estrogen related patterns and identify the fertile window, Ovul may give more context for when ovulation likely occurred. That can help users better understand when a mid luteal hormone test may be most relevant.
For postmenopausal women, both estrogen and progesterone are naturally lower. The Pg/E2 ratio can still be calculated, but it is interpreted differently, especially when hormone therapy is involved.
Progesterone to Estrogen Formula
To calculate the Pg/E2 ratio, both hormone concentrations must be in the same units. This is the step where most errors occur.
Pg/E2 ratio=Estradiol (E2)Progesterone (Pg)(after unit conversion)
Estradiol and Progesterone Unit Conversion
To calculate the Pg/E2 ratio, divide progesterone by estradiol after both are in the same unit.
Example:
Progesterone: 20,000 pg/mL
Estradiol: 100 pg/mL
20,000 ÷ 100 = 200
The Pg/E2 ratio is 200.
Estimation of the Progesterone to Estradiol Ratio
Once the units are the same, the calculation is straightforward:
Pg/E2 ratio = Progesterone in pg/mL ÷ Estradiol in pg/mL
Using the example above:
Pg = 20,000 pg/mL
E2 = 100 pg/mL
Pg/E2 ratio = 20,000 ÷ 100 = 200
In this example, the Pg/E2 ratio is 200.
Progesterone to Estrogen Normal Value
When measured in the mid luteal phase in healthy, cycling women, typical ranges are:
Progesterone (P, Pg): 11 to 29 ng/mL, or about 35 to 95 nmol/L
Estradiol (E2): 19 to 160 pg/mL, or about 70 to 600 pmol/L
After unit conversion, an often cited optimal Pg/E2 ratio for healthy women during the luteal phase is:
100 to 500
This means progesterone is 100 to 500 times higher than estradiol when both are measured in pg/mL. This range is commonly used by laboratories and integrative or functional medicine clinicians to describe a balanced luteal phase, as long as estradiol itself is within the normal luteal range.
Ovul can add helpful context before a blood test. Because estrogen changes across the follicular phase, fertile window, luteal phase, and perimenopause, a single “moment in time” blood test can be misleading. Ovul helps interpret estrogen saliva patterns over time, so users can better understand whether their estrogen trend looks expected for that phase of the cycle. If estrogen appears unusually elevated, unusually low, or inconsistent with cycle timing, that may be a reason to discuss blood hormone testing with a clinician.
How this ratio is used clinically
- 100–500 → suggests an adequate progesterone “buffer” against estradiol’s effects.
- <100 → suggests estrogen dominance (relative progesterone deficiency).
- >500 → suggests progesterone dominance, often in the context of supplementation.
Progesterone Dominance
Progesterone dominance means progesterone is disproportionately high relative to estradiol, often reflected as:
- Pg/E2 > 500
This pattern is:
- Relatively uncommon compared with estrogen dominance.
- Often iatrogenic—caused by high-dose progesterone or pregnenolone supplementation, rather than natural physiology (with the exception of pregnancy).
Possible symptoms of progesterone dominance:
- pronounced fatigue and drowsiness
- bloating, constipation, fluid retention
- low libido
- increased appetite or carb cravings
- mood flattening, irritability
Very high progesterone can also down-regulate estrogen receptors, so the body becomes relatively “deaf” to estrogen. This may paradoxically produce low-estrogen-like symptoms (hot flashes, vaginal dryness) despite normal estradiol levels, especially in postmenopausal women over-supplemented with progesterone.
Estrogen Dominance
Estrogen dominance describes a state where estrogen’s actions are inadequately balanced by progesterone. In Pg/E2 terms, this often appears as:
- Pg/E2 < 100
Key points:
- Estradiol may be normal or even low in absolute terms.
- The imbalance arises because progesterone is too low relative to estradiol, particularly in the luteal phase.
Common causes:
- anovulatory cycles (no ovulation → no corpus luteum → low progesterone)
- perimenopause (progesterone declines earlier and more sharply than estrogen)
- chronic stress (favoring cortisol over progesterone synthesis)
- obesity (adipose tissue converts androgens to estrogen via aromatase)
- liver overload, gut dysbiosis, or exposure to xenoestrogens (BPA, phthalates, etc.)
Symptoms and Consequences of Imbalance
Hormonal imbalance—whether estrogen dominance or progesterone dominance – can manifest broadly.
Common symptoms of estrogen dominance (low Pg/E2):
- heavy or prolonged menstrual bleeding
- more intense PMS or PMDD
- uterine fibroids, endometriosis, tender or fibrocystic breasts
- weight gain, especially hips, thighs, and abdomen
- water retention and bloating
- headaches or menstrual migraines
- anxiety, irritability, mood swings, “brain fog”
- low libido, fatigue, poor sleep
Common symptoms of progesterone dominance (high Pg/E2):
- fatigue, sedation, daytime sleepiness
- bloating, slower digestion
- low mood or emotional flattening
- low libido
- in some cases: signs of relative estrogen deficiency (e.g., vaginal dryness, hot flashes), especially if estrogen is already low (postmenopause)
The Ovul Hormone Tracker offers a modern, data-driven way to assess hormonal balance by analyzing the estradiol throughout the cycle. Ovul captures dynamic, real-time estrogen trends, allowing for a far more accurate understanding of the body’s natural fluctuations.
Long-term consequences of chronic imbalance
Chronic unopposed estrogen (low Pg/E2 for long periods) may contribute to:
- endometrial hyperplasia
- higher risk of certain hormone-sensitive cancers (endometrial, some breast cancers)
- progression of fibroids, endometriosis
- increased risk of recurrent miscarriage or implantation failure
Persistently distorted ratios can also negatively affect quality of life: pain, sleep issues, mood disorders, and sexual dysfunction.
Frequently Asked Questions
For cycling women tested in the mid-luteal phase, an often-used “good” or optimal Pg/E2 ratio is:
100–500 (progesterone/estradiol, both in pg/mL)
A result within this range generally suggests that progesterone sufficiently balances estradiol, assuming each hormone is also within its normal luteal phase range.
There is no single “perfect” number that applies to everyone. However:
Pg/E2 between 100 and 500 is commonly considered ideal in mid-luteal phase for healthy, cycling women.
“Ideal” also depends on your symptoms, age, and clinical situation (e.g., natural cycle vs. IVF vs. hormone therapy).
In practical terms, “normal” for cycling women is:
Pg/E2 ≈ 100–500 during the luteal phase.
Outside of this phase (e.g., follicular phase), the ratio is naturally much lower and should not be interpreted as pathological.
This is a trick of units.
- Estradiol is often reported in pg/mL.
- Progesterone is often reported in ng/mL (which is 1000× larger).
So numerically, progesterone (in ng/mL) may look similar to or lower than estrogen (in pg/mL), but once both are converted to pg/mL, progesterone should be much higher than estradiol during the luteal phase.
In a healthy luteal phase:
- Progesterone should dominate over estradiol.
Symptoms suggestive of high Pg/E2 (progesterone dominance) can include:
- excessive fatigue, daytime sleepiness
- a feeling of being “slowed down” or sedated
- bloating, constipation, fluid retention
- low libido
- mood flattening, apathy, or irritability
If you are on progesterone or pregnenolone supplements and have these symptoms with a very high Pg/E2 ratio, discuss dose adjustment with your healthcare provider.
In a healthy luteal phase, progesterone should be dominant relative to estrogen. This is normal physiology, not a problem.
However:
Chronic estrogen dominance (low Pg/E2) is associated with more clinically significant risks and symptoms (heavy bleeding, fibroids, endometrial changes, higher risk for some hormone-sensitive cancers).
Excessive progesterone dominance is less common but can still cause unpleasant symptoms and, in postmenopausal women, can worsen low-estrogen complaints.
So the goal is not “more progesterone at all costs”, but a balanced ratio appropriate to your life stage and clinical context.
During perimenopause:
- Ovulation becomes irregular → corpus luteum formation is inconsistent → progesterone falls first and most dramatically.
- Estradiol, although overall trending downward, can fluctuate widely and sometimes spike to higher-than-younger levels.
Result:
- The Pg/E2 ratio naturally decreases, creating a pattern of relative estrogen dominance.
This explains typical perimenopausal symptoms: heavier or erratic periods, worsening PMS and mood swings, sleep disturbances, breast tenderness, and sometimes hot flashes.
Menopause Age Calculator (Greene Climacteric Scale) | Ovul
Because it reflects functional balance rather than just absolute hormone levels. The Pg/E2 ratio:
- helps identify unopposed estrogen, which can disrupt the endometrium and menstrual pattern
- suggests whether luteal phase progesterone is sufficient to support implantation
- provides additional context in cases of infertility, recurrent miscarriage, or severe PMS/PMDD
In assisted reproduction (IVF/ICSI), both progesterone and estradiol levels—and their ratio—are monitored:
- Some studies have found that a high estradiol-to-progesterone ratio (E2/P) on the day of ovulation induction is associated with higher oocyte numbers and implantation rates.
Conversely, a high progesterone-to-estradiol (P4/E2) ratio at the wrong time (e.g., in some stimulated cycles) may signal premature endometrial maturation and reduced implantation chances, guiding clinicians to adjust protocols or defer embryo transfer.
Still have a question? Contact us?
Estrogen Ratio (Pg/E2)
Disclaimer
- Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization – PMC
- Evidence for a local change in the progesterone/estrogen ratio in human parturition at term – PubMed
- Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist – PubMed
- Progesterone – Wikipedia
- Estrogen – Wikipedia
- Estrogen Dominance – Whole Health Library
- Endocrine Disruptors | National Institute of Environmental Health Sciences
- Hormones in Beef: Myths vs. Facts
